• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION UNKNOWN PARIETEX UGYTEX MESH; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION UNKNOWN PARIETEX UGYTEX MESH; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number UNKPARUGYTEX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Bacterial Infection (1735); Cyst(s) (1800); Micturition Urgency (1871); Incontinence (1928); Unspecified Infection (1930); Pain (1994); Urinary Tract Infection (2120); Abnormal Vaginal Discharge (2123); Cramp(s) (2193); Discharge (2225); Urinary Frequency (2275); Injury (2348); Obstruction/Occlusion (2422); Prolapse (2475); Hematuria (2558); Blood Loss (2597); Intermenstrual Bleeding (2665); Dysuria (2684); No Code Available (3191)
Event Date 11/08/2007
Event Type  Injury  
Manufacturer Narrative
(b)(4).Manufacturer reference number: (b)(4).Lot number not provided.Udi not provided.Re-processing information not provided.Since the lot number was not provided, this information cannot be determined.(b)(4).
 
Event Description
The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.Product was used for therapeutic treatment.The patient underwent a mesh polypropylene cystocele repair with polypropylene midurethral sling.The pre-operative diagnosis was cystocele with stress urinary incontinence.The post-operative diagnosis was cystocele with stress urinary incontinence.The patient underwent an additional procedure on (b)(6) 2008.The procedure was a cystoscopy.The assessment was a uti.Per additional information received, the patient has experienced urinary tract infections (uti), vitamin d deficiency, and required additional surgical interventions.
 
Manufacturer Narrative
(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Per additional information received, procedure name/performed cystocele repair with polypropylene midurethral sling.The patient has experienced persistent hematuria, blood with intercourse, pain with intercourse, recurrent urinary tract infections, menorrhagia with hysteroscopy, dilation and curettage and novasure endometrial ablation, vaginal odor, urge incontinence, pelvic pain, spotting between periods, bacterial vaginosis, abdominal pain, grade one cystocele, mild residual, postmenopausal atrophic vaginitis, urinary frequency, ovarian cyst, menometrorrhagia, dysuria and required medical interventions such as multiple cystoscopies, antibiotic suppression, anticholinergics, and ptsn (percutaneous tibial nerve stimulation).
 
Manufacturer Narrative
Exemption number: e2013003.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of cystocele with stress urinary incontinence.It was reported that after implant, the patient experienced mobility with valsalva, recurrent urinary tract infections, frequent urination and voiding small amounts, blood with intercourse, recurrent pain with intercourse (dyspareunia), recurrent cystocele with valsalva, chronic recurrent infections, recurrent vaginitis, malodorous vaginal discharge, bulky uterus, menometrorrhagia, bacterial vaginosis, persistent hematuria, dysuria, frequency, interstitial cystitis, anteverted uterus, uterus with thickened endometrium, recurrent urge incontinence, female stress incontinence, spotting since her ablation, cramping and pain, watery discharge, palpable protuberant area along anterior aspect of mid vagina never noted previously, persistent vaginal bleeding, pelvic pain, left ovarian cyst, minimally atrophic vagina, possible adenomyosis, urgency, bladder leakage, frequency and urgency which occurred after intercourse, significant bladder instability, strong detrusor contraction with very poor flow rate concerning for possible obstruction, abdominal pain, postmenopausal atrophic vaginitis, segmental dysfunction of sacroiliac region, somatic dysfunction of sacroiliac region, getting up 5-6 times per night to urinate (nocturia), and incomplete bladder emptying.She required non-surgical and surgical interventions such as bioidentical hormone replacement, antifungals for chronic candidal infections, antibiotics for recurrent urinary tract infections, anticholinergics for urge incontinence, ct of abdomen and cystoscopies for persistent hemat uria, and percutaneous tibial nerve stimulation treatments for urge incontinence; hysteroscopy, dilation and curettage and novasure ablation for menorrhagia, and required additional surgical and non-surgical interventions.
 
Manufacturer Narrative
Exemption number: e2013003.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of cystocele with stress urinary incontinence.It was reported that after implant, the patient experienced mobility with valsalva, recurrent urinary tract infections, frequent urination and voiding small amounts, blood with intercourse, recurrent pain with intercourse (dyspareunia), recurrent cystocele with valsalva, chronic recurrent infections, recurrent vaginitis, malodorous vaginal discharge, bulky uterus, menometrorrhagia, bacterial vaginosis, persistent hematuria, dysuria, frequency, interstitial cystitis, anteverted uterus, uterus with thickened endometrium, recurrent urge incontinence, female stress incontinence, spotting since her ablation, cramping and pain, watery discharge, palpable protuberant area along anterior aspect of mid vagina never noted previously, persistent vaginal bleeding, pelvic pain, left ovarian cyst, minimally atrophic vagina, possible adenomyosis, urgency, bladder leakage, frequency and urgency which occurred after intercourse, significant bladder instability, strong detrusor contraction with very poor flow rate concerning for possible obstruction, abdominal pain, postmenopausal atrophic vaginitis, segmental dysfunction of sacroiliac region, somatic dysfunction of sacroiliac region, getting up 5-6 times per night to urinate (nocturia), and incomplete bladder emptying.She required non-surgical and surgical interventions such as bioidentical hormone replacement, antifungals for chronic candidal infections, antibiotics for recurrent urinary tract infections, anticholinergics for urge incontinence, ct of abdomen and cystoscopies for persistent hemat uria, and percutaneous tibial nerve stimulation treatments for urge incontinence; hysteroscopy, dilation and curettage and novasure ablation for menorrhagia, and required additional surgical and non-surgical interventions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN PARIETEX UGYTEX MESH
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION
116 avenue du formans
trevoux
FR 
Manufacturer (Section G)
SOFRADIM PRODUCTION
116 avenue du formans
trevoux
FR  
Manufacturer Contact
lisa hernandez
60 middletown avenue
north haven, CT 06473
2034925267
MDR Report Key6258688
MDR Text Key65028423
Report Number9615742-2017-00011
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 10/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKPARUGYTEX
Device Catalogue NumberUNKPARUGYTEX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/21/2016
Initial Date FDA Received01/17/2017
Supplement Dates Manufacturer Received12/21/2016
08/10/2018
10/16/2018
Supplement Dates FDA Received01/03/2018
08/10/2018
10/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age47 YR
-
-